Gyon Technologies Capital Management, LP Novo Nordisk A S Transaction History

Gyon Technologies Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $2.01 Million - $2.37 Million	19,436 New	19,436 $2.17 Million
Q1 2022 May 12, 2022	SELL	$93.1 - $112.54 $577,313 - $697,860	-6,201 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $34,420 - $42,031	-359 Reduced 5.47%	6,201 $695,000
Q3 2021 Nov 18, 2021	SELL	$84.42 - $106.62 $66,691 - $84,229	-790 Reduced 10.75%	6,560 $630,000
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $182,682 - $228,852	2,700 Added 58.06%	7,350 $616,000
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $311,829 - $352,562	4,650 New	4,650 $314,000
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $480,069 - $554,533	-7,514 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$63.69 - $70.22 $478,566 - $527,633	7,514 New	7,514 $522,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $1.43 Million - $1.66 Million	-24,478 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $1.21 Million - $1.59 Million	24,478 New	24,478 $1.47 Million

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.